The value ratio between CYL and NML continues to increase. Am still expecting a NML takeover, it makes no sense to have a circa 400% value gap. DYOR.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025